Corvas International, Inc.
Records under this name other than patents Corvas International, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Corvas International, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,132,398 | Method of Treatment of Hemorrhagic Disease Using a Factor Viia/Tissue Factor Inhibitor Formerly held Term ended Term ended Jan 29, 2024 · High confidence | Term ended | Term ended Jan 29, 2024 | High confidence |
| US 6,962,795 | Neutrophil inhibitors Formerly held Term ended Term ended Nov 8, 2022 · USPTO record | Term ended | Term ended Nov 8, 2022 | USPTO record |
| US 7,169,760 | Novel Peptides as NS3-SERINE Protease Inhibitors of Hepatitis C Virus Formerly held Term ended Term ended Nov 6, 2022 · High confidence | Term ended | Term ended Nov 6, 2022 | High confidence |
| US 7,244,721 | Novel Peptides as NS3-SERINE Protease Inhibitors of Hepatitis C Virus Formerly held Term ended Ended no later than Apr 15, 2022 · Medium confidence | Term ended | Ended no later than Apr 15, 2022 | Medium confidence |
| US 6,818,616 | Neutrophil inhibitors Formerly held Term ended Term ended Nov 16, 2021 · USPTO record | Term ended | Term ended Nov 16, 2021 | USPTO record |
| US 7,595,299 | Novel Peptides as NS3-SERINE Protease Inhibitors of Hepatitis C Virus Formerly held Term ended Ended no later than Oct 17, 2021 · Low confidence | Term ended | Ended no later than Oct 17, 2021 | Low confidence |
| US 6,800,434 | Novel Peptides as NS3-SERINE Protease Inhibitors of Hepatitis C Virus Formerly held Term ended Term ended Sep 7, 2021 · High confidence | Term ended | Term ended Sep 7, 2021 | High confidence |
| US 6,777,431 | Novel Non-Convalent Thrombin Inhibitors Formerly held Term ended Term ended Jul 13, 2021 · High confidence | Term ended | Term ended Jul 13, 2021 | High confidence |
| US 6,756,211 | Neutropohil inhibitors Formerly held Term ended Term ended Jun 29, 2021 · USPTO record | Term ended | Term ended Jun 29, 2021 | USPTO record |
| US 6,797,504 | Inhibitors of serine protease activity of matriptase or MTSP1 Formerly held Term ended Term ended Mar 15, 2021 · USPTO record | Term ended | Term ended Mar 15, 2021 | USPTO record |